The synthesis and luminescence of iridium(III) complexes containing new phenylpyridine (C(see test for symbol)N) ligands, 4-Me-4'-F-ppy, 4-Me-4'-CF3-ppy and 4-OMe-4'-CF3-ppy, were studied. These ligands were designed for development of the blue light-emitting iridium complexes by introducing the electron-withdrawing group (F, CF3) and the electron-donating group (Me, OMe) at the para positions of the phenyl and pyridine ligand rings, respectively. As an ancillary ligand, trzl-CMe3 was employed where trzl-CMe3 represents 2-(5-tert-butyl-2H-1,2,4-triazol-3-yl)pyridine. The resulting iridium complexes, Ir(4-Me-4'-F-ppy)2(trzl-CMe3), Ir(4-OMe-4'-CF3-ppy)2 (trzl-CMe3) and Ir(4-Me-4'-CF3-ppy)2(trzl-CMe3) exhibited the blue emission at 472, 484 and 494 nm in CH2Cl2 solution, respectively. Ir(4-Me-4'-F-ppy)2(trzl-CMe3) showed the most hypsochromic shift in photoluminescence (PL) among the complexes prepared herein. In the electroluminescence (EL) spectra, Ir(4-Me-4'-F-ppy)2(trzl-CMe3) and Ir(4-Me-4'-CF3-ppy)2(trzI-CMe3) exhibited the luminescence peak at 437 nm and 496 nm, respectively. In the aspect of blue emission color purity, Ir(4-Me-4'-F-ppy)2(trzl-CMe3) had the CIE coordinates of (0.176, 0.143), very close to the saturated standard blue emission.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.